Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001422 | 60.0218 | 2.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 80.9641 | 1.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 86.0369 | 1.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 88.0525 | 2.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 94.0416 | 3.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 98.0368 | 2.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 100.0522 | 1.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 100.0522 | 3.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 101.0112 | 3.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 102.0677 | 3.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 104.0470 | 1.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 110.0365 | 2.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 112.0155 | 1.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | OXALOACETIC ACID (M-H)-[-H2O] | 112.9853 | 0.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 114.0671 | 4.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 116.0472 | 2.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | SUCCINIC ACID (M-H)- | 117.0192 | 1.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | METHYLMALONIC ACID (M-H)- | 117.0193 | 1.53 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 118.0626 | 3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 118.0629 | 2.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 124.0515 | 4.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 124.0519 | 3.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 125.0472 | 3.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 126.0326 | 2.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 126.0675 | 7.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 126.0676 | 4.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | ITACONIC ACID (M-H)- | 129.0192 | 1.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 3-METHYL-2-OXOPENTANOIC ACID (M-H)- | 129.0549 | 4.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 4-METHYL-2-OXOPENTANOIC ACID (M-H)- | 129.0549 | 4.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | ISOLEUCINE (M-H)- | 130.0855 | 1.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 132.0420 | 2.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 132.0777 | 3.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 132.0778 | 3.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 132.0780 | 4.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 132.0784 | 5.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 134.0576 | 1.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 135.0678 | 4.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 136.0625 | 4.24 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 4-HYDROXYBENZOIC ACID (M-H)- | 137.0238 | 4.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 139.0624 | 1.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 139.0628 | 4.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 142.0618 | 3.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 142.0621 | 5.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 144.0417 | 3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 4-ACETAMIDOBUTANOIC ACID (M-H)- | 144.0662 | 1.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 144.0781 | 4.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | ADIPIC ACID (M-H)- | 145.0505 | 3.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 145.0734 | 2.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 146.0572 | 4.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 146.0684 | 5.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 146.0693 | 6.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 146.0929 | 7.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 146.0933 | 7.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | CITRAMALIC ACID (M-H)- | 147.0301 | 1.43 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 148.0719 | 3.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 148.0727 | 1.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 148.0727 | 3.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 148.0727 | 4.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 149.9565 | 0.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 149.9977 | 1.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 149.9985 | 1.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | XANTHINE (M-H)- | 151.0251 | 1.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 152.0467 | 4.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | L-HISTIDINE (M-H)- | 154.0624 | 0.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 154.0985 | 10.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 156.0055 | 1.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 158.0575 | 4.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 158.0924 | 6.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 158.0934 | 10.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | PIMELIC ACID (M-H)- | 159.0660 | 5.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 159.0874 | 3.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 159.0888 | 2.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 159.0889 | 4.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 159.0890 | 4.27 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 159.9315 | 1.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 159.9854 | 0.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 160.0724 | 7.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 160.0732 | 5.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 3-HYDROXY-3-METHYLGLUTARIC ACID (M-H)- | 161.0454 | 1.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 161.8488 | 0.53 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 162.0883 | 2.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 162.9937 | 1.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 163.0296 | 4.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 163.0297 | 6.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 163.0297 | 6.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 1-METHYLXANTHINE (M-H)- | 165.0416 | 2.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 3-METHYLXANTHINE (M-H)- | 165.0417 | 2.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 166.0485 | 2.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 168.0191 | 1.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 169.0371 | 2.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 169.0844 | 0.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 171.0890 | 5.61 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 171.0890 | 6.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 171.9832 | 3.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 172.0728 | 4.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | N-ACETYL-L-LEUCINE (M-H)- | 172.0967 | 7.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | SUBERIC ACID (M-H)- | 173.0809 | 8.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 173.1042 | 7.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 173.1044 | 7.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 173.1045 | 6.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 173.9980 | 3.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 174.0102 | 1.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 174.0881 | 2.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 174.0885 | 8.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | TRICARBALLYLIC ACID (M-H)- | 175.0231 | 1.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 176.0679 | 4.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 176.1028 | 6.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 176.1029 | 5.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 176.1033 | 4.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 176.1034 | 10.13 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 176.1036 | 4.24 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | HIPPURIC ACID (M-H)- | 178.0505 | 4.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | THEOPHYLLINE (M-H)- | 179.0561 | 4.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 180.0531 | 4.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | TYROSINE (M-H)- | 180.0640 | 1.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 4-PYRIDOXIC ACID (M-H)- | 182.0459 | 1.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 182.0570 | 4.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 182.0933 | 12.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 182.9984 | 3.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 183.0528 | 4.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 183.0888 | 7.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 184.1093 | 13.53 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 185.0679 | 3.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 185.1045 | 7.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 186.0883 | 9.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 186.1247 | 12.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 187.0474 | 2.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 188.0679 | 4.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 188.0680 | 3.53 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 189.0991 | 4.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 189.0995 | 5.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 189.9921 | 1.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 189.9930 | 2.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 189.9931 | 1.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 190.0830 | 4.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 190.0831 | 3.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 190.1194 | 6.15 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 190.1195 | 5.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | GLUCURONIC ACID (M-H)- | 193.0348 | 0.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 193.0736 | 6.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 193.9706 | 4.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 193.9882 | 1.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | GLUCONIC ACID (M-H)- | 195.0509 | 0.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 1,7-DIMETHYL URIC ACID (M-H)- | 195.0521 | 4.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 195.0524 | 11.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 195.0527 | 3.13 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 195.0528 | 3.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 196.0589 | 2.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 196.0700 | 8.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 198.0542 | 1.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 198.0744 | 1.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 198.0885 | 6.43 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 200.0681 | 4.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 200.1041 | 11.69 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 200.1042 | 11.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 200.1043 | 6.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 200.1058 | 11.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | SEBACIC ACID (M-H)- | 201.1122 | 12.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 202.1194 | 9.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 202.1195 | 6.19 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 202.1198 | 6.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | TRYPTOPHAN (M-H)- | 203.0817 | 3.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 204.0086 | 3.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 204.0088 | 4.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 204.0089 | 4.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | XANTHURENIC ACID (M-H)- | 204.0276 | 4.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 204.1345 | 9.19 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 204.1348 | 9.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 205.0038 | 3.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 205.9881 | 1.61 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 205.9884 | 2.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 206.0244 | 3.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 206.0402 | 1.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 206.0415 | 1.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 206.0419 | 1.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 206.0420 | 1.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 206.0774 | 2.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | N-ACETYL-L-PHENYLALANINE (M-H)- | 206.0809 | 7.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 206.0968 | 10.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 207.0524 | 3.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 207.0886 | 7.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 208.0035 | 2.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 209.0682 | 4.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 209.0712 | 3.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 210.0634 | 2.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 211.0331 | 2.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 212.0677 | 3.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 212.0679 | 4.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 213.0089 | 4.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 213.0092 | 3.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 213.0096 | 2.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 214.0833 | 4.43 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 214.0833 | 7.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 214.0925 | 0.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 214.1199 | 13.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 214.1558 | 18.42 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 215.0243 | 1.44 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | GLUCOSE (M+Cl)- | 215.0321 | 0.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 215.0343 | 4.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 216.0089 | 4.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 216.0990 | 6.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 216.0990 | 8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 216.0991 | 8.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 216.0992 | 7.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 216.1100 | 2.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 217.1045 | 1.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 217.9882 | 2.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 218.0238 | 3.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 218.0247 | 6.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 218.0250 | 7.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | PANTOTHENIC ACID (M-H)- | 218.1021 | 3.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 219.0727 | 1.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 219.1112 | 4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0029 | 3.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0032 | 1.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0036 | 2.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0037 | 3.44 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0038 | 3.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0042 | 3.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0044 | 4.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.0939 | 4.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.1294 | 4.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.1297 | 8.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.1299 | 8.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 220.1301 | 9.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 221.0806 | 7.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 221.9832 | 2.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 221.9840 | 1.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 222.0191 | 4.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 222.0193 | 4.27 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 222.0562 | 4.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 223.0564 | 0.61 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 223.0835 | 5.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 223.0837 | 4.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 223.9970 | 1.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 225.0631 | 4.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 226.0943 | 3.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 227.9731 | 0.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 228.1098 | 3.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 228.1101 | 4.15 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 228.1351 | 15.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 228.1355 | 17.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 229.0038 | 2.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 229.0039 | 3.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 229.0042 | 2.27 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 229.0396 | 3.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 4-ACETAMINOPHEN SULFATE (M-H)- | 230.0116 | 2.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 230.1254 | 2.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 230.1254 | 4.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 230.1256 | 4.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 230.1509 | 16.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 231.0196 | 3.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 231.1096 | 5.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 231.1096 | 7.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 231.1096 | 7.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 232.0033 | 4.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 232.0039 | 4.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 233.0355 | 1.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 233.0886 | 3.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 234.0190 | 5.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 234.0191 | 2.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 234.0193 | 2.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 234.0195 | 6.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 235.0870 | 5.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 236.0785 | 4.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 237.0246 | 2.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 237.0632 | 3.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 237.0723 | 0.61 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 237.0838 | 1.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 237.0995 | 6.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 238.0116 | 4.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 239.9755 | 3.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 242.1145 | 10.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 242.1259 | 6.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 242.1260 | 6.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 242.1265 | 5.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 242.1508 | 16.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 243.0195 | 5.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 243.0556 | 4.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 244.1299 | 9.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 244.1300 | 11.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 244.1414 | 6.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 244.1420 | 7.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 244.1666 | 17.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 244.2026 | 21.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 246.0193 | 3.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 246.1207 | 3.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 247.1049 | 6.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 247.9988 | 2.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 247.9988 | 3.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 248.0333 | 3.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 248.0889 | 8.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 249.1024 | 5.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 249.1027 | 6.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.0129 | 2.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.0194 | 3.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.0681 | 2.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.0691 | 3.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.0935 | 4.69 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.1306 | 4.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 250.1397 | 1.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 251.0785 | 6.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 251.0786 | 7.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 253.0110 | 3.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 253.0924 | 7.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | PALMITOLEIC ACID (M-H)- | 253.2177 | 22.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | PANTOTHENIC ACID (M+Cl)- | 254.0784 | 3.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 254.0891 | 3.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 254.0993 | 1.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 254.1254 | 4.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 254.1257 | 3.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | PALMITIC ACID (M-H)- | 255.2339 | 22.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 256.0013 | 5.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 256.1409 | 8.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 256.1418 | 8.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 256.8286 | 5.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 258.1461 | 14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 258.1822 | 19.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 259.0146 | 2.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 259.0513 | 3.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 259.0669 | 1.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 260.1253 | 7.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 260.1357 | 6.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 260.1359 | 3.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 260.1360 | 4.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 260.1363 | 4.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 261.0305 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 262.0142 | 4.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 262.0151 | 3.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 262.0910 | 4.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 263.9992 | 3.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 264.1110 | 5.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 265.9933 | 3.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 266.0636 | 1.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 268.0521 | 2.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 268.0919 | 6.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 268.1145 | 2.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 268.1410 | 8.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 269.9496 | 2.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 269.9811 | 2.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 270.0669 | 2.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 270.0735 | 4.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 270.1200 | 6.43 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 270.1572 | 9.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 272.0353 | 5.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 272.0770 | 3.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 272.2342 | 21.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 272.2342 | 22.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 272.2345 | 22.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 273.1752 | 16.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 273.9661 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 274.0146 | 6.32 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 274.1520 | 5.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 274.1771 | 13.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 274.1772 | 11.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 275.0092 | 2.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 275.0461 | 3.61 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 276.0289 | 3.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 277.1672 | 21.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 278.0101 | 4.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 278.1013 | 6.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 278.1530 | 21.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 278.1710 | 11.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | LINOLEIC ACID (M-H)- | 279.2335 | 22.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 279.9166 | 0.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 280.0247 | 5.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 280.0785 | 1.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 280.1043 | 3.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 280.1051 | 2.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 280.1185 | 7.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | OLEIC ACID (M-H)- | 281.2495 | 22.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 282.1205 | 7.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 283.0123 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 283.0543 | 3.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | XANTHOSINE (M-H)- | 283.0691 | 2.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | STEARIC ACID (M-H)- | 283.2652 | 23.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 284.1259 | 13.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 285.0952 | 3.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 285.1318 | 4.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 286.0681 | 1.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 286.1512 | 3.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 286.1518 | 4.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 286.1518 | 5.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 286.1733 | 7.42 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 287.9712 | 1.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 288.0301 | 4.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 288.1318 | 6.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 288.1320 | 6.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 289.9434 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 292.0835 | 0.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 293.1367 | 6.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 293.9654 | 1.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 294.0230 | 4.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 294.0256 | 3.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 294.1821 | 17.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 295.0727 | 3.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 296.1359 | 8.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 296.1462 | 5.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 296.2339 | 21.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 296.9909 | 2.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 297.1064 | 2.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 298.0688 | 5.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 298.0915 | 2.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 298.1867 | 15.24 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 298.2496 | 22.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 299.0668 | 3.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 300.0680 | 2.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 300.0854 | 6.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 300.1315 | 4.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 300.2652 | 22.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 301.0785 | 4.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 302.0632 | 2.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 302.0984 | 4.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 302.1021 | 7.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 302.2450 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 303.0451 | 0.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 303.0782 | 6.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 303.1420 | 3.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | ARACHIDONIC ACID (M-H)- | 303.2331 | 22.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 304.0798 | 3.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 304.0882 | 2.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 304.0884 | 1.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 304.9177 | 4.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 305.0931 | 4.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 305.9188 | 0.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 306.0405 | 5.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 306.2550 | 22.82 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 308.0035 | 3.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 308.0129 | 3.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 309.0840 | 3.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 309.0858 | 4.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 310.0657 | 3.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 310.1132 | 5.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 310.1133 | 6.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 310.1259 | 5.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 310.9762 | 2.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 311.1225 | 3.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 312.0841 | 6.24 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 312.1286 | 7.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 314.0971 | 3.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 316.0790 | 4.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 316.2599 | 21.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 317.1563 | 4.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 318.0398 | 3.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 318.0665 | 2.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 318.1316 | 11.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 320.0739 | 1.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 320.1108 | 4.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 320.1478 | 13.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 320.2337 | 21.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 321.0628 | 0.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 321.0689 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 322.2493 | 21.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 323.0625 | 2.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 324.0295 | 11.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 324.1286 | 8.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 324.1664 | 11.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 324.2273 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 325.0792 | 4.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 325.0795 | 3.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 325.0796 | 4.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | P-ACETAMIDOPHENYL BETA-D-GLUCURONIDE (M-H)- | 326.0901 | 2.26 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 326.1032 | 9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 326.1036 | 8.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 327.0949 | 4.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 327.0950 | 6.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | DOCOSAHEXAENOIC ACID (M-H)- | 327.2342 | 22.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 3',5'-CYCLIC AMP (M-H)- | 328.0472 | 1.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 328.1012 | 2.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 328.2583 | 22.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 329.0747 | 3.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 329.1106 | 6.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 329.1581 | 5.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 330.0947 | 2.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 330.2763 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 332.0677 | 4.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 332.0979 | 5.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 332.1475 | 13.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 332.1826 | 15.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 332.1900 | 1.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 334.1616 | 15.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 334.8395 | 2.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 335.0968 | 2.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 336.0441 | 1.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 337.0794 | 6.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 337.1262 | 4.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 338.0638 | 4.42 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 339.0947 | 2.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 339.0948 | 4.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 339.0953 | 4.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 340.0724 | 3.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 340.0826 | 8.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 340.1724 | 6.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 341.9536 | 0.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 342.0926 | 2.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 342.1303 | 6.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 342.1315 | 9.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 342.2296 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 344.0738 | 3.13 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 344.0742 | 3.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 344.1067 | 4.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 344.1467 | 14.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 344.1479 | 13.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 346.1621 | 15.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 346.1622 | 11.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 346.1625 | 11.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 346.1627 | 8.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 347.0996 | 3.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 347.1584 | 4.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.0812 | 3.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1047 | 5.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1574 | 8.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1758 | 7.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1765 | 5.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1772 | 9.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1777 | 13.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1782 | 16.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.1785 | 12.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.2264 | 22.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 348.8553 | 5.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 350.0244 | 2.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 350.1576 | 11.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 350.2429 | 22.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 351.0954 | 6.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 352.2584 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 353.0940 | 12.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 354.1518 | 6.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 355.0909 | 4.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 355.8938 | 3.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 355.8940 | 3.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 356.0438 | 2.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 356.1106 | 9.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 356.1646 | 22.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 357.9307 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 358.0372 | 0.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 358.0895 | 4.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 358.2692 | 17.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 360.0473 | 1.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 360.0570 | 2.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 360.1056 | 1.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 360.1413 | 6.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 362.0839 | 5.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 362.1567 | 7.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 362.1573 | 6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 362.2118 | 21.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 364.0196 | 1.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 364.1728 | 7.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 366.0248 | 2.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 366.1133 | 10.19 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 366.1141 | 9.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 366.1422 | 2.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 366.1870 | 8.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 367.0929 | 3.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 367.1086 | 13.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 368.0440 | 4.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 368.1102 | 6.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 368.1655 | 15.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 369.9787 | 3.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 370.0108 | 1.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 370.0890 | 5.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 370.0916 | 8.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 370.1630 | 16.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 371.0852 | 4.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 371.1682 | 2.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 372.0368 | 2.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 372.1063 | 7.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 372.1070 | 7.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 373.8506 | 3.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 374.0049 | 1.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 374.1208 | 7.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 374.1216 | 7.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 374.1934 | 18.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 376.0278 | 5.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 376.1362 | 3.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 376.1365 | 9.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 376.1369 | 6.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 376.1372 | 5.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 376.1382 | 22.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 378.0250 | 2.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 378.1514 | 7.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 378.1517 | 4.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 378.1524 | 7.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 379.0247 | 3.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 379.9224 | 0.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 380.0409 | 4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 380.0987 | 4.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 380.1190 | 2.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 382.0260 | 1.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 382.1388 | 8.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 382.1860 | 22.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.0372 | 2.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.1047 | 5.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.1607 | 13.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.1616 | 11.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.1748 | 10.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.1964 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 384.1986 | 7.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 385.9537 | 3.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 385.9830 | 1.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 386.1079 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 386.1968 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 388.0218 | 1.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 388.0683 | 2.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 388.1716 | 7.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 388.1740 | 13.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 388.1744 | 12.72 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 390.0994 | 11.19 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | DEOXYCHOLIC ACID (M-H)- | 391.2846 | 21.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | HYODEOXYCHOLIC ACID (M-H)- | 391.2867 | 22.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 392.1451 | 8.26 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 392.2049 | 16.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 392.2051 | 16.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 394.1414 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 395.1415 | 2.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 396.1043 | 8.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 398.0012 | 1.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 398.0104 | 5.44 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 398.1336 | 7.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 398.1777 | 7.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 400.0359 | 3.15 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 400.1721 | 7.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 400.1722 | 6.69 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 400.1732 | 7.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 401.2199 | 22.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 401.9687 | 2.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 402.0242 | 4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 402.1163 | 4.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 402.1842 | 7.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 402.1858 | 6.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 402.1860 | 7.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 403.9242 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 404.1244 | 3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 404.1702 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 406.0233 | 1.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 406.1840 | 12.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 406.2197 | 8.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 408.0527 | 3.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 408.0622 | 3.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 408.1783 | 18.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 409.0690 | 3.26 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 409.9413 | 0.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 410.2392 | 6.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 412.0881 | 3.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 412.0920 | 0.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 412.1059 | 3.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 413.0639 | 1.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 414.0005 | 1.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 414.1014 | 4.22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 414.1409 | 23.19 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 415.3281 | 21.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 415.9844 | 2.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 416.0429 | 6.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 417.3440 | 21.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 417.3443 | 22 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 417.9415 | 2.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 418.2209 | 17.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 418.2210 | 17.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 418.2293 | 22.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 419.0510 | 2.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 419.1163 | 1.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 420.1266 | 1.34 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 420.1585 | 22.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 420.2365 | 18.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 420.2375 | 18.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 421.1227 | 4.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 421.1473 | 3.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 424.0827 | 9.42 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 424.9522 | 5.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 424.9849 | 2.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 425.0563 | 1.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 425.9181 | 0.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 426.2227 | 6.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 427.0874 | 0.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | DEOXYCHOLIC ACID (M+Cl)- | 427.2697 | 21.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 427.9361 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 428.2040 | 9.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 428.2238 | 8.69 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 429.0947 | 2.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 429.9651 | 2.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 430.0000 | 3.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 430.0443 | 3.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 430.1415 | 5.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 430.1607 | 3.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 430.1867 | 22.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 430.3057 | 21.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 431.3027 | 21.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 432.1196 | 3.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 432.2013 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 434.1216 | 11.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 434.1535 | 6.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 434.1547 | 6.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 434.2146 | 14.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 435.9579 | 3.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 436.1481 | 6.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 436.1482 | 3.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 436.2307 | 16.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 438.2969 | 21.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 440.1421 | 4.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 440.1430 | 4.76 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 440.1684 | 9.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 442.1669 | 12.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 442.2014 | 8.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 442.2211 | 17.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 442.9959 | 2.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 444.0950 | 4.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 444.1577 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 444.1634 | 16.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 445.1394 | 5.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 445.9947 | 2.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 446.0873 | 11.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 446.0996 | 3.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 446.2146 | 11.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 447.9787 | 1.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 448.0015 | 3.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 448.0948 | 1.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 448.2466 | 21.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 449.3106 | 20.63 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 450.2606 | 21.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 450.2616 | 21.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 451.1333 | 2.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 452.1253 | 5.32 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 452.1866 | 7.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 453.0168 | 5.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 454.0938 | 0.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 454.1015 | 3.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 454.1037 | 3.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 454.1845 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 455.9341 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 458.0965 | 1.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 459.0941 | 3.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 459.9810 | 5.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 459.9812 | 5.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 460.1593 | 9.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 460.2798 | 21.74 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 461.2034 | 4.66 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 462.1665 | 5.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 462.1882 | 9.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 462.1892 | 9.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 462.1902 | 14.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 464.0626 | 3.93 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 464.2055 | 8.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 464.2414 | 17.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 465.3079 | 15.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 465.3091 | 14.24 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 466.1128 | 6.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 466.1445 | 2.77 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 466.2053 | 8.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 466.2479 | 20.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 466.2562 | 19.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 467.0125 | 0.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 467.0558 | 2.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 468.0979 | 1.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 468.1596 | 7.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 468.2716 | 20.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 472.0161 | 8.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 472.1130 | 1.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 472.1570 | 22.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 472.2503 | 9.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 472.2665 | 20.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 473.0930 | 3.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 473.9287 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 474.1070 | 5.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 474.1467 | 5.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 475.1587 | 3.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 476.1628 | 3.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 476.2578 | 10.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 476.2604 | 9.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 476.3307 | 21.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 477.2859 | 22.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 478.0982 | 5.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 478.1835 | 10.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 479.3002 | 22.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 479.9907 | 2.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 479.9925 | 2.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 480.1485 | 3.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 480.2350 | 14.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 480.2353 | 14.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 480.2354 | 13.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 480.2363 | 13.15 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 482.1352 | 5.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 482.1420 | 8.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 482.2146 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 482.2489 | 16.46 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 482.2504 | 14.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 482.2520 | 16.6 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 484.2676 | 16.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 485.2418 | 3.92 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 485.2454 | 3.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 486.0791 | 5.14 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 486.1086 | 17.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 486.2285 | 9.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 486.2373 | 21.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 487.0197 | 2.48 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 489.0891 | 0.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 489.1734 | 1.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 490.2785 | 18.9 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 491.1046 | 3.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 491.1563 | 4.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 491.2303 | 5.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 492.2725 | 18.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 493.1150 | 3.47 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 494.0713 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 494.0922 | 1.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 494.2863 | 21.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 494.2881 | 19.53 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 494.2885 | 20.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 496.2302 | 9.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 496.3001 | 17.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 496.3045 | 19.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 496.3047 | 19.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 498.0773 | 3.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 498.9864 | 2.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 499.1325 | 3.53 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 500.1842 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 501.2847 | 22.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 501.2849 | 22.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 503.2996 | 22.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 505.1124 | 2.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 505.1454 | 4.19 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 506.2343 | 6.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 506.2352 | 5.61 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 506.2514 | 14.51 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 507.1230 | 1.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 508.2193 | 21.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 509.1105 | 2.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 509.1382 | 2.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 509.8792 | 0.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.1638 | 13.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.2656 | 7.13 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.2815 | 15.27 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.2828 | 15.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.2829 | 17.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.2833 | 16.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 510.2841 | 17.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 511.0762 | 0.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 511.0968 | 2.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 511.2498 | 2.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 512.1145 | 3.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 512.2989 | 17.97 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 512.2996 | 18.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 513.0935 | 3.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 515.0957 | 2.5 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 515.2116 | 3.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 515.2918 | 18.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | EPIBRASSINOLIDE [ISTD] (M+Cl)- | 515.3124 | 19.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
| AN001422 | 516.2338 | 21.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 516.2772 | 10.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 517.1729 | 5.04 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 517.9021 | 0.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 517.9827 | 2.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 518.0755 | 3.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 518.1905 | 3.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 518.2483 | 21.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 520.1363 | 4.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 520.2048 | 8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 521.1389 | 4.17 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 522.0761 | 5.15 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 523.9209 | 0.56 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 524.0653 | 0.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 524.1307 | 3.45 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 525.2858 | 22.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.1128 | 2.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.2750 | 14.67 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.2762 | 12.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.2763 | 12.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.2765 | 15.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.2774 | 14.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.2776 | 12.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 526.3499 | 19.79 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 527.1277 | 4.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 528.1277 | 4.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 528.1882 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 528.2301 | 15.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 530.1127 | 5.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 530.2568 | 9.98 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 532.0888 | 3.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 532.2807 | 19.89 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 533.3179 | 17.4 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 534.2648 | 8.24 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 534.4626 | 22.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 535.1543 | 4.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 536.1189 | 5.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 536.1210 | 5.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 536.1849 | 5.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 537.1939 | 3.78 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 537.2580 | 22.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 537.8922 | 0.58 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 538.2734 | 10.12 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 539.1268 | 3.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 540.1387 | 22.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 540.1665 | 4.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 540.2560 | 13.49 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 541.3355 | 22.32 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 542.1454 | 9.44 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 542.2727 | 14.26 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 542.3426 | 18.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 542.3435 | 18.15 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 543.1205 | 4.25 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 544.0365 | 0.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 544.0444 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 544.4739 | 24.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 546.1050 | 5.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 546.2501 | 7.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 546.2600 | 15.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 547.2870 | 22.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 548.0414 | 1.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 548.3032 | 10.11 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 550.0526 | 1.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 550.1856 | 21.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 550.2026 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 550.2037 | 5.31 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 552.1731 | 6.57 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 552.2553 | 16.73 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 552.3284 | 21.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 554.2615 | 19.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 555.1515 | 4.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 556.2191 | 23.2 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 558.2658 | 5.55 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 560.1651 | 7.75 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 560.2303 | 7.29 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 560.3040 | 10.65 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 561.1109 | 3.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 562.2749 | 20.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 562.2752 | 19.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 564.2894 | 19.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 564.2909 | 19.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 565.9592 | 3.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 566.0288 | 1.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 566.0903 | 4.35 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 567.3527 | 22.43 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 568.1686 | 23.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 568.2417 | 16.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 568.3235 | 18.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 568.3238 | 20.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 569.1402 | 2.95 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 569.2730 | 22.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 570.1879 | 21.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 573.4886 | 24.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 574.2124 | 4.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 574.2832 | 10.59 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 574.3492 | 22.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 575.1215 | 4.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 575.1243 | 4.37 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 576.2056 | 21.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 578.2695 | 15.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 578.2701 | 18.01 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 578.2705 | 17.64 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 578.3788 | 22.18 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 578.3793 | 21.99 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 579.2057 | 6.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 580.2176 | 21.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 580.2280 | 5.05 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 580.2861 | 18.94 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 581.0024 | 3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 581.1393 | 4.82 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 582.0998 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 582.1413 | 4.88 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 582.2989 | 10.69 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 583.5174 | 24.52 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 584.1216 | 3.96 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 586.1144 | 3.08 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 586.2009 | 18.1 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 586.2100 | 5.91 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 586.2352 | 21.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 587.1300 | 3.39 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 587.1350 | 1.06 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 588.5141 | 22.82 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 590.1545 | 22.85 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 590.1944 | 3.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 590.2777 | 8.07 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 590.3052 | 18.68 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 590.5242 | 23.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 592.1055 | 3.28 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 592.3180 | 7.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 592.3276 | 10.7 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 594.2134 | 19.54 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 596.0381 | 1.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 596.0601 | 0.83 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 596.3899 | 21.81 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 596.4287 | 22.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 597.1211 | 5.23 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 600.1632 | 4.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 601.3949 | 11.71 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 601.9896 | 5.42 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 602.1420 | 4.33 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 602.2997 | 8.21 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 602.5292 | 22.84 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 603.2345 | 13.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 604.0828 | 1.41 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 604.1757 | 5.02 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 604.1935 | 21.8 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 604.2570 | 8.03 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 604.3300 | 11.16 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 604.3798 | 22.87 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 606.0719 | 3.86 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 608.0064 | 5.38 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 608.0738 | 3.09 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 608.3544 | 21.3 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 608.3546 | 19.62 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN001422 | 610.2602 | 14.36 | Minutes | ST000855 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
